UK markets closed

Eliem Therapeutics, Inc. (ELYM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.81+0.12 (+1.38%)
At close: 04:00PM EDT
8.91 +0.10 (+1.14%)
After hours: 04:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close8.69
Open8.63
Bid8.65 x 100
Ask9.12 x 100
Day's range8.52 - 9.25
52-week range2.34 - 11.55
Volume179,497
Avg. volume896,339
Market cap262.118M
Beta (5Y monthly)-0.31
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

    Transaction to add clinical-stage program directed towards treating unmet needs in autoantibody-mediated diseases Combined company expected to have approximately $210 million of cash and cash equivalents, including $120 million from a concurrent private placement of common stock from leading life sciences investors Combined company to focus on clinical development of lead product candidate, TNT119, in upcoming Phase 2 clinical trials in systemic lupus erythematosus and immune thrombocytopenia Co